Amitkumar Mehta
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 58
- Oncology 55
- CAR-T cell therapy research 43
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Nilanjan Ghosh (24 shared papers)Andres Forero‐Torres (5 shared papers)Nancy L. Bartlett (6 shared papers)Joanna Zurko (2 shared papers)Alex F. Herrera (7 shared papers)Izidore S. Lossos (15 shared papers)Matthew A. Lunning (8 shared papers)Javier Muñoz (4 shared papers)
- Journals
- Blood (29 papers)Journal of Clinical Oncology (17 papers)Hematological Oncology (9 papers)Blood Advances (6 papers)Transplantation and Cellular Therapy (4 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Amitkumar Mehta
108 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 74
- Oncology 834
- Pathology and Forensic Medicine 515
- Genetics 213
- Immunology 349
- Dermatology 74
Countries citing papers authored by Amitkumar Mehta
This map shows the geographic impact of Amitkumar Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amitkumar Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amitkumar Mehta more than expected).
Fields of papers citing papers by Amitkumar Mehta
This network shows the impact of papers produced by Amitkumar Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amitkumar Mehta. The network helps show where Amitkumar Mehta may publish in the future.
Co-authors
The 25 scholars most cited alongside Amitkumar Mehta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 114 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 107 | |
| 2 | 2019 | 93 | |
| 3 | 2019 | 89 | |
| 4 | 2020 | 47 | |
| 5 | 2016 | 47 | |
| 6 | 2019 | 47 | |
| 7 | 2023 | 41 | |
| 8 | 2015 | 35 | |
| 9 | 2022 | 34 | |
| 10 | 2015 | 30 | |
| 11 | 2016 | 28 | |
| 12 | 2020 | 27 | |
| 13 | 2018 | 26 | |
| 14 | 2013 | 26 | |
| 15 | 2021 | 26 | |
| 16 | 2023 | 24 | |
| 17 | 2018 | 22 | |
| 18 | 2019 | 21 | |
| 19 | 2016 | 21 | |
| 20 | 2015 | 19 |
About Amitkumar Mehta
Amitkumar Mehta is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 114 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (58 papers), CAR-T cell therapy research (43 papers), Chronic Lymphocytic Leukemia Research (32 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), Cutaneous lymphoproliferative disorders research (15 papers), Immune Cell Function and Interaction (7 papers), Cancer Immunotherapy and Biomarkers (6 papers) and CNS Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (834 citations), Pathology and Forensic Medicine (515 citations), Genetics (213 citations), Immunology (349 citations) and Dermatology (74 citations). Amitkumar Mehta has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Nilanjan Ghosh, Andres Forero‐Torres, Nancy L. Bartlett, Joanna Zurko, Alex F. Herrera, Izidore S. Lossos, Matthew A. Lunning, Javier Muñoz, Charalambos Andreadis and Jeremy S. Abramson. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, Blood Advances and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.